Tue.Nov 07, 2023

article thumbnail

Pulse oximeters’ inaccuracies in darker-skinned people require urgent action, AGs tell FDA

STAT

More than two dozen attorneys general are urging Food and Drug Administration officials to take urgent action to address disparities in how well pulse oximeters, the fingertip devices used to monitor a person’s oxygen levels, work on people with darker skin. In a Nov. 1 letter, the AGs noted that it had been a year since the FDA convened a public meeting of experts , who called for clearer labeling and more rigorous testing of the devices, and that no action had been taken.

Labelling 350
article thumbnail

Shock of the old: 10 scandalous vintage medicines – from asthma cigarettes to cocaine wine

The Guardian - Pharmaceutical Industry

Cure any ailment! Never known to fail! Early medicine adverts made grand claims but they look alarming today The confusion with patent medicines starts with the name, since they were rarely ever patented; manufacturers just thought it sounded cool. Bamboozling was always part of the package: from the 17th century, concoctions of water, alcohol and herbs were sold with wild claims and exotic origin stories.

Packaging 143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

STAT

The number of babies born with congenital syphilis in the United States has soared over the last decade, leading to an increase in stillbirths, infant deaths, and life-altering birth defects, the Centers for Disease Control and Prevention reported Tuesday. The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequa

336
336
article thumbnail

23andMe CEO Anne Wojcicki’s vision for changing healthcare as a ‘full-fledged biotech’

PharmaVoice

23andMe always had bigger aims than at-home genetics testing. In this in-depth interview, the company’s founder explains its foray into pharma, drug R&D, solving cold cases and more.

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Senate confirms Monica Bertagnolli as NIH director

STAT

Longtime cancer doctor Monica Bertagnolli is finally heading to the National Institutes of Health director’s office after a nearly two-year effort to install a permanent leader atop the $48 billion science agency. The Senate voted 62-36 Tuesday to confirm her nomination, giving the White House clearance to officially name Bertagnolli the institute’s director, the second woman ever to fill the role.

319
319
article thumbnail

Frontiers Health 2023 Day One

pharmaphorum

Frontiers Health 23 - Day 1 from the marvellous Auditorium della Tecnica in Rome, where we are set to bring you the biggest news stories, trends, and industry insights

118
118

More Trending

article thumbnail

An obesity drug biotech gets buy-in from Eli Lilly, venture firms

BioPharma Dive

Startup OrsoBio raised $60 million in a Series A round co-led by Longitude Capital and Enavate Sciences, and joined by the pharma’s venture arm.

117
117
article thumbnail

Sen. Bernie Sanders moves toward another hearing with pharma CEOs

STAT

You’re reading the web edition of D.C. Diagnosis.  Sign up here  to receive this newsletter in your inbox on Tuesdays and Thursdays. On the hot seat, feeling the Bern Drug executives will soon have the chance to tell Congress why they’re suing Medicare over price negotiations when their companies sell drugs to all the other governments that negotiate prices, my colleague John Wilkerson reports.

article thumbnail

Gilead reveals positive data for potential first-line adenocarcinoma treatment

European Pharmaceutical Review

Positive results for a combination treatment using the first Fc-silent investigational monoclonal antibody in pivotal clinical trials that is designed to block and bind to the T-cell immunoreceptor with Ig and ITIM domains (TIGIT), have been announced. The treatment is being evaluated in patients with upper GI adenocarcinomas. Domvanalimab plus the antibody zimberelimab and chemotherapy showed encouraging overall response rate and six-month progression-free survival (PFS) rate results in a preli

article thumbnail

STAT+: Drug shortages and the supply chain are a matter of national security, experts say

STAT

WASHINGTON — The pandemic showed how fragile the supply chain can be, and to fix it, the United States needs to treat health care like a national security issue, said experts at a health conference here on Monday. Rep. Debbie Dingell (D-Mich.), speaking on a panel at the Milken Institute’s Future of Health Summit, warned that if the country had another pandemic or faced a bacterial biowarfare threat, “and we don’t have the capability to produce antibiotics in our coun

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Biogen, Sage set price of postpartum depression pill at $15,900

BioPharma Dive

The price is below what some analysts had predicted and significantly less than $34,000 Sage initially set for its earlier postpartum infusion, Zulresso.

113
113
article thumbnail

STAT+: Remote patient monitoring helped manage hypertension better, but at a higher cost

STAT

During the pandemic, in search of tools to keep patients healthy and virus-free, doctors turned to a new technology for help: remote patient monitoring. In 2020, home use of tools like connected blood pressure cuffs, continuous glucose monitors, and weight scales shot up, with billing for the devices and their associated care more than quadrupling. As use of remote patient monitoring has continued to grow — albeit at a slower rate than during the early-pandemic surge — data on its

255
255
article thumbnail

Sanofi Issues Update on Shortages of Beyfortus for Respiratory Syncytial Virus

PharmExec

Due to a higher than anticipated demand, Sanofi is carefully managing distribution of 50 mg doses of Beyfortus in the private market to fulfill existing orders and provide equitable access to remaining doses for the vaccine that protects infants against respiratory syncytial virus.

Vaccines 111
article thumbnail

STAT+: FDA cites cancer links in seeking to withdraw approval of antibiotic used in pigs

STAT

After years of trying, the Food and Drug Administration is again seeking to withdraw approval of an antibiotic that is widely used by farmers to control diarrhea in their pigs, but has generated controversy over links to cancer. At issue is carbadox , which, since the 1970s, has been added to livestock feed to combat diarrhea in young pigs after they are weaned from their mothers, as well as to promote growth.

244
244
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

GLP1R-targeting drugs dominate type 2 diabetes pipeline: GlobalData

Express Pharma

The type 2 diabetes (T2D) landscape has historically been dominated by insulin receptor (IR) targeting drugs. However, driven by the success of recent glucagon-like peptide 1 receptor (GLP1R)-targeting drugs, there has been a surge in the number of active pipeline drugs addressing this target. This indicates a shift from the conventional IR to the GLP1R as the primary target for pioneering T2D treatments, says GlobalData.

Diabetes 111
article thumbnail

Opinion: A fertility clinic failure destroyed my chance at motherhood

STAT

Kindbody, a fast-growing fertility chain, knowingly exposed countless eggs and embryos to unsafe conditions and suffered repeated embryo mix-ups, according to a months-long Bloomberg investigation published recently. Here we go again.

229
229
article thumbnail

The ‘elegant science’ in achieving the promise of ADCs

pharmaphorum

In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.

article thumbnail

STAT+: FDA’s Woodcock, other experts highlight persistent issues plaguing pharma, biotech in the wake of Covid-19

STAT

WASHINGTON — Current and former government officials proffered a clear-eyed, and often depressing, take Tuesday on the state of clinical trials, the pharmaceutical industry, and biotech investors coming out of the Covid-19 pandemic. The officials, including the Food and Drug Administration’s second-in-command Janet Woodcock, acknowledged the drug industry’s persistent lack of interest in collaborating on clinical trials, the ways hypercompetition pervades academic research a

Vaccines 220
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

BioNTech flashes the cash, adding tumour drug in $1bn deal

pharmaphorum

BioNTech flashes the cash, adding tumour drug in $1bn deal Phil.

110
110
article thumbnail

STAT+: FTC challenges several big drugmakers over inaccurate or improper patent listings

STAT

Making good on a recent threat, the Federal Trade Commission is challenging more than 100 patents on brand-name medicines that were improperly or inaccurately listed by some of the world’s biggest drug companies in a key government registry. The agency notified 10 companies that listings for dozens of patents on such medicines as asthma inhalers and epinephrine autoinjectors are being disputed.

article thumbnail

Flagship expands into Asia-Pacific with new Singapore hub

BioPharma Dive

The biotech company creator hopes its new office will help its portfolio companies grow and strike partnerships in the region.

109
109
article thumbnail

Mind-altering ketamine becomes latest pain treatment, despite little research or regulation

STAT

WASHINGTON (AP) — As U.S. doctors scale back their use of  opioid painkillers , a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a  trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions.

207
207
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

BREAKING: Breast cancer drug licensed as preventative measure

Outsourcing Pharma

A breast cancer drug that has been used for many years to treat the disease, has been licensed today (November 7) as a preventative measure.

107
107
article thumbnail

Opinion: STAT+: The PATCH Act’s approach to securing medical devices actually gives malicious actors a blueprint

STAT

In August 2013, the FDA made news when it issued cybersecurity guidance for medical devices. But several years earlier, government officials recognized the risk: Soon after the FDA made its announcement, former Vice President Dick Cheney revealed in a “60 Minutes” interview that when his pacemaker was replaced in 2007, his doctors took precautions to make it hack-proof.

173
173
article thumbnail

Access Insights 2023: The Pharmacy of the Future

Pharmaceutical Commerce

Conference session discusses the drivers, practical considerations, success factors, and landscape for next-generation pharmacy innovation.

105
105
article thumbnail

Your morning biotech news roundup

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a CRISPR delay, some curious biotech language, and the derailment of a promising startup.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The Unified Patent Court: assessing the impact on European life sciences patent litigation

European Pharmaceutical Review

It has been more than three months since the Unified Patent Court (UPC) and the European patent with unitary effect (unitary patent) came into full force on 1 June 2023, adding a new layer of options to the existing European patent system of national courts and European patents. The unitary patent is a new, single pan-European right protecting an invention, which prohibits anyone but the owner or their licensee from using that invention in all participating EU Member States.

article thumbnail

STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation

STAT

Top of the morning to you. Gray skies are hovering over the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us.

article thumbnail

Generic breast cancer drug cleared for prevention in England

pharmaphorum

Generic breast cancer drug cleared for prevention in England Phil.

104
104
article thumbnail

STAT+: FTC’s Lina Khan makes a stop at Y Combinator, how telehealth helps rural America

STAT

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.  Sign up to get it  delivered in your inbox every Tuesday and Thursday.  The  Federal Trade Commission chair Lina Khan dropped by the hallowed startup incubator last week, part of what she said was an effort to hear directly from smaller players who don’t have the lobbying clout of tech giants.

156
156
article thumbnail

Health Innovators – Søren Møller

pharmaphorum

Søren Møller, managing partner for seed investments at Novo Holdings, has successfully supported numerous healthcare startups through strategic investments.

103
103